1. 2010
  2. Inhibition of HIV-1 by non-nucleoside reverse transcriptase inhibitors via an induced fit mechanism-importance of slow dissociation and relaxation rates for antiviral efficacy. / Elinder, M; Selhorst, P; Vanham, G; Oberg, B; Vrang, L; Danielson, UH.

    In: Biochemical Pharmacology, Vol. 80, No. 8, 2010, p. 1133-1140.

    Research output: Contribution to journalA1: Web of Science-article

  3. In vitro evaluation of viability, integrity and inflammation in genital epithelia upon exposure to pharmaceutical excipients and candidate microbicides. / Gali, Y; Delezay, O; Brouwers, J; Addad, N; Augustijns, P; Bourlet, T; Hamzeh-Cognasse, H; Ariën, KK; Pozzetto, B; Vanham, G.

    In: Antimicrobial Agents and Chemotherapy, Vol. 54, No. 12, 2010, p. 5105-5114.

    Research output: Contribution to journalA1: Web of Science-article

  4. Development of an in vitro dual-chamber model of the female genital tract as a screening tool for epithelial toxicity. / Gali, Y; Ariën, KK; Praet, M; Van den Bergh, R; Temmerman, M; Delezay, O; Vanham, G.

    In: Journal of Virological Methods, Vol. 165, No. 2, 2010, p. 186-197.

    Research output: Contribution to journalA1: Web of Science-article

  5. Differential activity of candidate microbicides against early steps of HIV-1 infection upon complement virus opsonization. / Jenabian, MA; Saidi, H; Charpentier, C; Bouhlal, H; Schols, D; Balzarini, J; Bell, TW; Vanham, G; Belec, L.

    In: Aids Research and Therapy, Vol. 7, 2010, p. 16.

    Research output: Contribution to journalA4: Article in journal not included in A1, A2 or A3

  6. Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian HTLV-1-infected patients. / Talledo, M; López, G; Huyghe, JR; Verdonck, K; Adaui, V; González, E; Best, I; Clark, D; Vanham, G; Gotuzzo, E; Van Camp, G; Van Laer, L.

    In: Journal of Medical Virology, Vol. 82, No. 3, 2010, p. 460-466.

    Research output: Contribution to journalA1: Web of Science-article

  7. The role of KIR gene content and HLA-C group in susceptibility to HTLV-1-associated myelopathy / tropical spastic paraparesis in Peru. / Talledo, M; López, G; Huyghe, JR; Verdonck, K; González, E; Clark, D; Senitzer, D; Vanham, G; Gotuzzo, E; Van Camp, G; Van Laer, L.

    In: Human Immunology, Vol. 71, No. 8, 2010, p. 804-808.

    Research output: Contribution to journalA1: Web of Science-article

  8. Transcriptome analysis of monocyte-HIV interactions. / Van den Bergh, R; Florence, E; Vlieghe, E; Boonefaes, T; Grooten, J; Houthuys, E; Tran Thi, TH; Gali, Y; De Baetselier, P; Vanham, G; Raes, G.

    In: Retrovirology, Vol. 7, 2010, p. 53.

    Research output: Contribution to journalA1: Web of Science-article

  9. Analysis of infectious virus clones from two HIV-1 superinfection cases suggests that the primary strains have lower fitness. / van der Kuyl, AC; Kozaczynska, K; Ariën, KK; Gali, Y; Balazs, VR; Dekker, SJ; Zorgdrager, F; Vanham, G; Berkhout, B; Cornelissen, M.

    In: Retrovirology, Vol. 7, 2010, p. 60.

    Research output: Contribution to journalA1: Web of Science-article

  10. Role of dendritic cells in HIV-immunotherapy. / Van Gulck, E; Van Tendeloo, VF; Berneman, ZN; Vanham, G.

    In: Current HIV Research, Vol. 8, No. 4, 2010, p. 310-322.

    Research output: Contribution to journalA1: Web of Science-article

Previous 1...4 5 6 7 8 9 10 11 ...20 Next

ID: 4718